Clear Guide Medical
Baltimore, US · Founded 2010 · Maryland corporation
Clear Guide Medical develops image-guidance technology, including the Clear Guide SCENERGY system, that provides precision targeting for ultrasound-guided invasive procedures while reducing the need for intermediate imaging. Its products are used by clinicians and resident learners in emergency medicine and other specialties, and are compatible with existing ultrasound equipment.
HardwareHealthtechMedical Devices
Founders & leadership
DH
DOROTHEE HEISENBERGExecutive Officer, Director, Promoter
PJ
PHILIPP JAKOB STOLKAExecutive Officer, Director, Promoter
JJ
James J CondonDirector, Promoter
PC
Paul ClarkDirector, Promoter
DH
Dorothee HeisenergExecutive Officer, Director, Promoter
Reported raises · per SEC filings
Form D private placements▶$1.2MraisedAug 2016 · 5 investors · Other Health CareRule 506(b)
▶$1.2MraisedAug 2016 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James J CondonDirector, Promoter
- Paul ClarkDirector, Promoter
- Dorothee HeisenergExecutive Officer, Director, Promoter
- Offering amount
- $1.3M
- Amount sold
- $1.2M
- Minimum investment
- $25K
- First sale
- Aug 2016
- Incorporated
- Corporation, Maryland, 2015
- Federal exemptions
- 06b
▶$3.6MofferedApr 2015 · Other Health CareRule 506(b)
▶$3.6MofferedApr 2015 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DOROTHEE HEISENBERGExecutive Officer, Director, Promoter
- PHILIPP JAKOB STOLKAExecutive Officer, Director, Promoter
- Offering amount
- $3.6M
- Minimum investment
- $25K
- Proceeds to insiders
- $200K
- Incorporated
- Limited Liability Company, Maryland, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 13 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $311.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $259.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $250.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $251.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $234.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $987.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $399K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $148.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $200K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.